4//SEC Filing
Opexa Therapeutics, Inc. 4
Accession 0001140361-14-010988
CIK 0001069308operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:28 PM ET
Size
7.1 KB
Accession
0001140361-14-010988
Insider Transaction Report
Form 4
Rill Donna R
Senior V.P. of Operations
Transactions
- Award
Common Stock
2014-02-28+12,363→ 32,765 total - Award
Employee Stock Option (Right to Buy)
2014-02-28+64,625→ 64,625 totalExercise: $1.82Exp: 2024-02-28→ Common Stock (64,625 underlying)
Footnotes (2)
- [F1]Vests in full on February 28, 2015.
- [F2]25% excercisable on the one year anniversary of the date of grant with the balance vesting quarterly over the remaining three years.
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001069308
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:28 PM ET
- Size
- 7.1 KB